Corteva (CTVA) director receives 2,350-share stock award and holds 35,853

Rhea-AI Filing Summary

Corteva, Inc. director Nayyar Nayaki R reported acquiring common stock through a compensation-related award. On this Form 4, the insider received 2,350 shares of Corteva common stock at a stated price of $0.0000 per share, described as a grant or award.

Following this transaction, the director directly holds a total of 35,853.3934 shares of Corteva common stock. A related footnote explains that the total includes the acquisition of 76.1249 shares through dividend reinvestment, indicating part of the position increased automatically as dividends were reinvested rather than through open-market purchases.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Nayyar Nayaki R

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,350	$0.00	--

Holdings After Transaction: Common Stock — 35,853.393 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 2,350 shares Grant price per share: $0.0000 per share Total shares after transaction: 35,853.3934 shares +2 more

5 metrics

Shares granted 2,350 shares Common stock grant or award on Form 4

Grant price per share $0.0000 per share Stated transaction price for stock award

Total shares after transaction 35,853.3934 shares Direct holdings following the award

Dividend reinvestment shares 76.1249 shares Acquired via dividend reinvestment per footnote

Transactions acquiring shares 1 transaction Transaction summary acquireCount

Key Terms

Grant, award, or other acquisition, dividend reinvestment, Form 4

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

dividend reinvestment financial

"Includes acquisition of 76.1249 shares pursuant to dividend reinvestment"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

Form 4 regulatory

"This Form 4, the insider received 2,350 shares of Corteva common stock"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nayyar Nayaki R

(Last) (First) (Middle)

C/O CORTEVA, INC.

9330 ZIONSVILLE ROAD

(Street)

INDIANAPOLIS INDIANA 46268

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Corteva, Inc. [ CTVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/28/2026		A		2,350	A	$0	35,853.3934(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes acquisition of 76.1249 shares pursuant to dividend reinvestment.

	/s/Abigail Jarrell, by power-of-attorney	04/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Corteva (CTVA) report for Nayyar Nayaki R?

Corteva reported that director Nayyar Nayaki R acquired 2,350 shares of common stock via a grant or award. This was recorded on a Form 4 filing and reflects a compensation-related share award rather than an open-market stock purchase or sale.

How many Corteva (CTVA) shares does Nayyar Nayaki R hold after this Form 4?

After the reported grant, Nayyar Nayaki R directly holds 35,853.3934 Corteva common shares. This total includes both the 2,350-share award and 76.1249 additional shares acquired through dividend reinvestment, as noted in the filing’s footnote disclosure.

Was the Corteva (CTVA) Form 4 transaction an open-market buy or sell?

The Form 4 shows a grant or award acquisition, not an open-market trade. The 2,350 Corteva shares were received at a stated price of $0.0000 per share, indicating a compensation-related award rather than a discretionary market purchase or sale by the director.

What does the dividend reinvestment note mean in the Corteva (CTVA) Form 4?

The footnote explains that 76.1249 Corteva shares were acquired via dividend reinvestment. This means cash dividends owed on existing holdings were automatically used to buy fractional additional shares, increasing the director’s position without separate market transactions.

Does the Corteva (CTVA) Form 4 show any stock option exercises or derivative activity?

The filing’s derivative summary is empty, indicating no reported stock option exercises or other derivative transactions. The only reported activity is a non-derivative grant or award of 2,350 Corteva common shares and additional shares from dividend reinvestment.